This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors. Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.
Study Type
OBSERVATIONAL
Enrollment
500
Power Life Sciences
San Francisco, California, United States
Number of hidradenitis suppurativa patients who decide to enroll in a clinical research
Time frame: 3 months
Rate of hidradenitis suppurativa patients who remain in clinical trial to trial completion
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.